DARLENE BONADONA: Open Payments
NPI 1891179982 · GONZALES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,084 in 69 payments from 24 companies in 2025. Trend: 2023 $1,805 · 2024 $1,766 · 2025 $2,084
Food & beverage: $2,084
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 4 | $261 |
| Corcept Therapeutics | 8 | $223 |
| Amgen Inc. | 5 | $182 |
| Radius Health, Inc. | 9 | $182 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $179 |
| Novo Nordisk Inc | 4 | $162 |
| Madrigal Pharmaceuticals | 1 | $130 |
| Insulet Corporation | 6 | $110 |
| Dexcom, Inc. | 1 | $105 |
| Xeris Pharmaceuticals, Inc. | 3 | $64 |
Products named: iLet Bionic Pancreas, Korlym, Tymlos, Kerendia, Ozempic, REZDIFFRA, REPATHA, Omnipod.
Industry payments across LA — which companies pay providers there.
